Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

University of Surrey announces Animal Health Innovation Network
The network will use state-of-the-art technology to address global health issues.

Network will address zoonotic diseases and antibiotic resistance. 

The University of Surrey has announced a new network, The Animal Health Innovation Network, which will tackle animal-to-human virus transmission, antimicrobial resistance, sustainable food supply and pet welfare.

Partnering with organisations across Surrey and Hampshire, the network will also see the university working with the Enterprise M3 (EM3), Local Enterprise Partnership, and centres including The Pirbright Institute, the Animal and Plant Health Agency (APHA), the Veterinary Medicines Directorate (vmd) and Sparsholt College.

Professor Alasdair Cook, head of vHive, the University of Surrey's veterinary health innovation hub, said: "I am delighted to be working with prestigious organisations across the region as part of the Animal Health Innovation Network. 

"The network will use the University of Surrey's cutting-edge expertise in machine learning and artificial intelligence to create new veterinary solutions that benefit the health of our pets who, of course, play a critical role in supporting our mental and physical health. 

“Another goal is for the network to contribute to the global discussion of how we make our food supply more sustainable so we can eliminate hunger and improve the health of our planet.”

The network will also work alongside industry partners, including Zoetis, the global animal health company.

Dr Theo Kanellos, director of business development and commercial alliances at Zoetis commented: "The Animal Health Innovation Network has a unique concentration of expertise and infrastructures through their partnering organisations that could bring disruptive innovation in digital, data analytics, diagnostics, biodevices, vaccines, and overall control of animal infectious diseases. 

“This novel type of public-private network will accelerate the development and adoption of new technologies that could contribute to the quest for global sustainability."

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.